Austin, Texas; May 21, 2020 — Elligo Health Research, a healthcare-enabling research organization, was founded to encourage collaboration and data sharing that makes clinical research more effective. As we transition to a post-pandemic environment, Elligo will host a webinar discussing the tools and technological innovations needed to enable access to clinical research as a care option while offering insights about how to keep trials moving forward with new standards.

Discussing Continuing Clinical Research Innovations After COVID-19 will be presented by Eli Alford, chief operating officer. Hosted by Xtalks, this webinar will take place June 4 from 1–2 p.m. EDT and explore how COVID-19 has acted as a catalyst for clinical research innovations that drive trial efficiencies to make it easier for patients to participate. Register here.

About Elligo Health Research

Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Powered by our Goes Direct® approach and novel IntElligoSM Research Stack clinical technology, our team provides access to the best healthcare experts, patients, and research technologies. We engage physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products. Learn more at elligodirect.com.